首页 | 本学科首页   官方微博 | 高级检索  
     

白细胞介素-6在酒精性肝病中的作用
引用本文:崔玮,崔迪. 白细胞介素-6在酒精性肝病中的作用[J]. 中国生物化学与分子生物学报, 2021, 37(4): 467-474. DOI: 10.13865/j.cnki.cjbmb.2020.10.1414
作者姓名:崔玮  崔迪
作者单位:(湖南大学体育学院人体科学实验室,长沙 410000)
基金项目:湖南省体育局体育科学学会重点项目(No.2018XH001)和湖南省体育局体育科学学会一般项目(No.2020XH030)资助
摘    要:酒精性肝病(alcoholic liver disease,ALD)是由于长期过量饮酒导致肝的内部组织发生炎症损伤的慢性肝病.乙醇及其衍生物在代谢过程中直接或间接诱导引起的肝炎症反应可能是ALD发病的重要机制.然而,该过程内在的细胞分子机制尚不明确.最新研究发现,白细胞介素-6(interleukin-6,IL-6)对...

关 键 词:白细胞介素-6  酒精性肝病  炎症反应  信号转导和转录激活因子3  核转录因子-kB
收稿时间:2020-07-30

The Role of Interleukin-6 in Alcoholic Liver Disease
CUI Wei,CUI Di. The Role of Interleukin-6 in Alcoholic Liver Disease[J]. Chinese Journal of Biochemistry and Molecular Biology, 2021, 37(4): 467-474. DOI: 10.13865/j.cnki.cjbmb.2020.10.1414
Authors:CUI Wei  CUI Di
Affiliation:(Human Science Laboratory, Department of Physical Education, Hunan University, Changsha 410000, China)
Abstract:Alcoholic liver disease (ALD) is a chronic liver disease in which the internal liver tissues are inflammation damaged caused by long-term excessive drinking. Direct or indirect induction of hepatic inflammatory response by ethanol and its derivatives in the metabolic process may be an important mechanism of ALD, but the underlying cellular and molecular mechanisms of this process are still unclear. Recent study found that interleukin-6 (IL-6) response to ethanol mediated inflammation of the liver cells with dual role. It is involved in an inflammatory process that drives alcohol damage, activate cell apoptosis signaling pathways to stimulate macrophage and lymphocyte acute reactive protein synthesis aggravate the inflammatory response, and can lead to liver cell regeneration, increase anti-inflammatory cytokine levels play anti-inflammatory function to improve the degree of liver injury, and exercise stress can cause muscle source sex IL-6 temporary increased significantly, change the liver oxidation-inflammatory state. Then the body is kept in the adaptive state of long-term anti-inflammation to prevent the inflammatory damage of liver cells. Based on deepening the understanding of ALD inflammation pathological mechanism at the same time, the review on alcoholic liver cell inflammation related factor change and the IL-6 regulation pathway, considering the clinical use of IL-6 joint inflammatory factor pathway of targeted therapy is expected to be a novel therapy, the feasibility for laboratory screening of inflammatory related ALD drug intervention, for the prevention of alcoholic liver disease and treatment to provide new targets and train of thought.
Keywords:
点击此处可从《中国生物化学与分子生物学报》浏览原始摘要信息
点击此处可从《中国生物化学与分子生物学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号